[Parasitology] Collaborative Drug Discovery Next Generation Database for both Private and Public Open Access

Barry Bunin via parasite%40net.bio.net (by bbunin from collaborativedrug.com)
Mon Jul 9 20:01:30 EST 2007


Dear Kosta Y. Mumcuoglu,

 

Thanks for your continued interest in the Collaborative Drug Discovery (CDD)
Database and community.  We are pleased to share with you news of our latest
release of the software with our first Public Community data, including a
list of the FDA and Orphan Approved Drugs courtesy of Dr. Christopher
Lipinski as well as data from leading Neglected Disease Researchers around
the world.  

 

In the July 2007 release of the Database, CDD has completely overhauled the
user interface to make it easier to navigate and comprehend, has simplified
the batch uploading of molecule and assay data, and has made the entire
application more robust.  For a free access to the community data or for a
commercial private group just email register from collaborativedrug.com to set it
up in one call and online web demo at http://www.collaborativedrug.com/. 

 

-Barry A. Bunin, PhD

Collaborative Drug Discovery (CDD)

 

P.S.  I've also included the full recent press release below:

 

FOR IMMEDIATE RELEASE: 

 

Headline:  Collaborative Drug Discovery Releases Next Generation Database
for both Private Collaborations and Public Open Access.

 

San Francisco, Calif., Jul, 5 /PRNewswire/ -- Collaborative Drug Discovery
(CDD, Inc) is pleased to announce the introduction of its next generation
database technology. Collaborative Drug Discovery's Web-based database
enables scientists to collaborate in novel, global efforts to more
effectively develop new drug candidates for commercial and humanitarian
markets. The technology enables novel community-based research efforts that
become more and more useful as additional participants contribute data.
Publicly available data sets currently in the system include the FDA orphan
and approved drugs and small molecule drug discovery data dating back over
half a century. These data sets pertain to a diverse group of neglected
diseases, including malaria, tuberculosis, African Sleeping Sickness, Chagas
Disease and Leishmania.

 

Customers can also securely archive, mine, and collaborate around their
small molecule preclinical drug discovery data in invitation-only,
username-password protected groups.  

 

The CDD Database is one of the easiest to use drug discovery informatics
platforms available today. In designing the product, CDD has focused on
making it easy enough for first year graduate students to use, yet powerful
enough to satisfy the needs of experienced drug discovery scientists.  In
the July 2007 release of the Database, CDD has completely overhauled the
user interface to make it easier to navigate and comprehend, has simplified
the batch uploading of molecule and assay data, and has made the entire
application more robust and secure.

 

Researchers can choose to keep their data private or share any or all of it
with other research groups in the community. By default, labs using the CDD
database only share their imported data privately with fellow lab members. A
subset of the data is available openly to the public at no cost (please
contact register from collaborativedrug.com for access).

 

Using the CDD technology, researchers can:  

 

*	Permanently archive their drug-centric data
*	Mine chemical and biological data for lead optimization
*	Access data instantaneously and securely
*	Connect with multidisciplinary experts, yielding new insights
*	Avoid duplication of research effort
*	Optimize the use of valuable research resources
*	Facilitate current and future collaborations
*	Accelerate target validation and drug discovery 
*	Leverage a practical mechanism to maximize the benefit of
collaborative data while minimizing intellectual property protection costs

 

 

For more information please visit: http://www.collaborativedrug.com/
<http://www.collaborativedrug.com/pages/news> 
 
About Collaborative Drug Discovery:  Collaborative Drug Discovery (CDD) has
developed a customizable, web-based database to archive, mine, and
collaborate with preclinical drug discovery data.  CDD enables scientists to
more effectively develop new drug candidates for commercial and humanitarian
markets. CDD supports a global community - here is a subset of private
groups currently supported:  Drugs for Neglected Diseases Initiative, Marine
Biological Laboratory, Seattle Biomedical Research Institute, Stanford
University, St. Jude Children's Research Hospital, University of California
Berkeley, University of California Los Angeles, University of California San
Francisco, University of California Santa Cruz, University of Cape Town,
University of Mississippi, University of Pennsylvania, University of Sydney,
University of Washington, Louisiana State University.
 
 
Contact:
 

Barry A. Bunin, PhD

President

Collaborative Drug Discovery, Inc.

1818 Gilbreth Road, Suite 220
Burlingame, CA 94010
Tel: 650-204-3084

Email: info from collaborativedrug.com 

 

 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://www.bio.net/bionet/mm/parasite/attachments/20070709/9e215da5/attachment.html


More information about the Parasite mailing list